CTMP inhibits AKT phosphorylation with subsequent inhibition of the PI3K/AKT pathway [28], and FDFT1 negatively regulates the AKT/mTOR signal to inhibit glycolysis and proliferation in colon cancer [29]. This evidence concerns the gene AKT1 and malignant colon neoplasm.